HopeStage
Back to all studies
TerminatedNCT05250570

Distress Tolerance for Benzodiazepine Discontinuation

Behavioural studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Pittsburgh and 2 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 17, 2022
Recruitment status
Terminated
Enrollment listed in the registry
1
Sponsor
University of Pittsburgh
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT05250570
Official title
Show the full official title

Distress Tolerance vs. Relaxation Therapy for Benzodiazepine Discontinuation in Patients Receiving Opioid Agonist Therapy

Recruitment & locations

Terminated

Pittsburgh · Wilkinsburg

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Pittsburgh, a university.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies